BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

132 related articles for article (PubMed ID: 6745299)

  • 1. Uptake of 75Se-selenocholesterol by an adrenal cortical carcinoma and its metastases.
    Reschini E; Peracchi M
    Eur J Nucl Med; 1984; 9(6):291-3. PubMed ID: 6745299
    [TBL] [Abstract][Full Text] [Related]  

  • 2. A black adrenocortical adenoma causing Cushing's syndrome not imaged by radiocholesterol scintigraphy.
    Reschini E; Baldini M; Cantalamessa L
    Eur J Nucl Med; 1990; 17(3-4):185-7. PubMed ID: 2279500
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Uptake of 75Se-selenomethylcholesterol by a nonfunctioning adrenocortical adenoma.
    Reschini E; Catania A; Silva A; Cantalamessa L
    J Nucl Med Allied Sci; 1984; 28(3):221-4. PubMed ID: 6530626
    [No Abstract]   [Full Text] [Related]  

  • 4. Adrenal scintigraphy with 75Se selenonorcholestenol: a review.
    Sudell CJ; Blake GM; Gossage AA; Cullen DR; Munro DS
    Nucl Med Commun; 1985 Sep; 6(9):519-27. PubMed ID: 4069475
    [TBL] [Abstract][Full Text] [Related]  

  • 5. [Scintigraphic investigations of the adrenals by means of 75Se-selenocholesterol (author's transl)].
    Jakubowski W; Feltynowski T; Graban W
    Pol Przegl Radiol Med Nukl; 1980; 44(4):307-10. PubMed ID: 7243634
    [No Abstract]   [Full Text] [Related]  

  • 6. Cushing's syndrome due to a black adenoma of the adrenal gland: lack of tumour visualization by radiocholesterol scintigraphy.
    Ambrosi B; Colombo P; Faglia G
    Eur J Nucl Med; 1994 Dec; 21(12):1367-8. PubMed ID: 7875176
    [No Abstract]   [Full Text] [Related]  

  • 7. Gallbladder visualization with radiocholesterol simulating bilateral adrenal uptake.
    Dominguez-Gadea L; Diez L; Rueda MD; Crespo A
    Clin Nucl Med; 1995 Mar; 20(3):270-1. PubMed ID: 7750225
    [No Abstract]   [Full Text] [Related]  

  • 8. Clinical experience with 75Se selenomethylcholesterol adrenal imaging.
    Shapiro B; Britton KE; Hawkins LA; Edwards CR
    Clin Endocrinol (Oxf); 1981 Jul; 15(1):19-27. PubMed ID: 7307282
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Adrenal cortical adenoma causing Cushing's syndrome: correct localization by functional scintigraphy despite nonlocalizing morphological imaging studies.
    Geatti O; Fig L; Shapiro B
    Clin Nucl Med; 1990 Mar; 15(3):168-71. PubMed ID: 2317996
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Selenium-75-19-selenocholesterol-a new adrenal scanning agent with high concentration in the adrenal medulla.
    Sarkar SD; Ice RD; Beierwaltes WH; Gill SP; Balachandran S; Basmadjian GP
    J Nucl Med; 1976 Mar; 17(3):212-7. PubMed ID: 1249631
    [TBL] [Abstract][Full Text] [Related]  

  • 11. False localization of an aldosteronoma by dexamethasone-suppressed adrenal scintigraphy.
    Herd GW; Semple PF; Parker D; Davidson JK; Hilditch TE; Fraser R
    Clin Endocrinol (Oxf); 1987 Jun; 26(6):699-705. PubMed ID: 3665124
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Scintigraphy of the adrenal glands using 75Se-selenocholesterol (Scintadren).
    Jakubowski W; Graban W; Feltynowski T; Bazko E; Elwertowski M
    Radiobiol Radiother (Berl); 1982; 23(3):325-32. PubMed ID: 7178467
    [No Abstract]   [Full Text] [Related]  

  • 13. Does the corticoadrenal adenoma with "pre-Cushing's syndrome" exist?
    Charbonnel B; Chatal JF; Ozanne P
    J Nucl Med; 1981 Dec; 22(12):1059-61. PubMed ID: 6273512
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Clinical experience with the adrenal scanning agents iodine 131-19-iodocholesterol and selenium 75-6-selenomethylcholesterol.
    Reschini E; Catania A
    Eur J Nucl Med; 1991; 18(10):817-23. PubMed ID: 1743205
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Scintigraphic patterns of adrenocortical carcinoma: morpho-functional correlates.
    Barzon L; Zucchetta P; Boscaro M; Marzola MC; Bui F; Fallo F
    Eur J Endocrinol; 2001 Dec; 145(6):743-8. PubMed ID: 11720899
    [TBL] [Abstract][Full Text] [Related]  

  • 16. [75Se]Selenomethylcholesterol uptake in familial congenital Cushing's.
    Shapiro B; Grant DB; Britton KE
    J Nucl Med; 1982 Sep; 23(9):799-800. PubMed ID: 7108628
    [No Abstract]   [Full Text] [Related]  

  • 17. Selenium-75-cholesterol imaging and computed tomography of the adrenal glands in differentiating the cause of Cushing's syndrome.
    Miller JL; Smith JA; Mervis B; Roman T
    S Afr Med J; 1983 May; 63(22):848-50. PubMed ID: 6857400
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Adrenal scintigraphy of well-differentiated (functioning) adrenocortical carcinomas: potential surgical pitfalls.
    Pasieka JL; McLeod MK; Thompson NW; Gross MD; Schteingart DE
    Surgery; 1992 Nov; 112(5):884-90. PubMed ID: 1440240
    [TBL] [Abstract][Full Text] [Related]  

  • 19. [Nuclear medicine diagnostic localization in primary aldosteronism and Cushing syndrome].
    Sialer G; Marincek B; Mengden T; Vetter W
    Bildgebung; 1987-1989; 56(4):157-62. PubMed ID: 3078253
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Adrenocortical scintigraphy.
    Troncone L; Danza FM
    Rays; 1992; 17(1):34-9. PubMed ID: 1636016
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 7.